A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine
暂无分享,去创建一个
Dipali Sharma | N. Davidson | J. Keen | D. Sharma | Nancy E. Davidson | Judith Clancy Keen | Lan Yan | Kelly M. Mack | Catherine Pettit | Dawn Smith | Catherine Pettit | K. Mack | Lan Yan | Dawn Smith
[1] P. Marks,et al. Histone deacetylases and cancer: causes and therapies , 2001, Nature Reviews Cancer.
[2] S. Kern,et al. A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. , 2000, Cancer research.
[3] J. Herman,et al. Synergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells , 2001 .
[4] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[5] R. Momparler,et al. Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells , 2001, Cancer Chemotherapy and Pharmacology.
[6] H. Iwase. Molecular action of the estrogen receptor and hormone dependency in breast cancer , 2003, Breast cancer.
[7] S. Baylin,et al. Altered methylation patterns in cancer cell genomes: cause or consequence? , 2002, Cancer cell.
[8] R C Coombes,et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] S. Baylin,et al. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.
[10] Kuang-Hung Cheng,et al. Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code , 2003, Annals of the New York Academy of Sciences.
[11] C. Allis,et al. Acetylation and chromosomal functions. , 2000, Current opinion in cell biology.
[12] Rachel Jones,et al. Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.
[13] C. Allis,et al. Translating the Histone Code , 2001, Science.
[14] N. Davidson,et al. Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] R A Rifkind,et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. , 2000, Cancer research.
[16] M. Carducci,et al. Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors , 2000, Expert opinion on investigational drugs.
[17] J. Herman,et al. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. , 2000, Cancer research.
[18] N. Davidson,et al. Role of DNA Methylation and Histone Acetylation in Steroid Receptor Expression in Breast Cancer , 2001, Journal of Mammary Gland Biology and Neoplasia.
[19] A. Bird. Methylation Talk Between Histones and DNA , 2001, Science.
[20] S. Baylin,et al. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.
[21] A. Bird,et al. Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.
[22] N. Davidson,et al. The biology of breast carcinoma , 2003, Cancer.
[23] J. Woodgett,et al. Phosphatidylinositol 3′ Kinase Signaling in Mammary Tumorigenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.
[24] V. Richon,et al. Histone deacetylase inhibitors as new cancer drugs , 2001, Current opinion in oncology.
[25] T. R. Hebbes,et al. A direct link between core histone acetylation and transcriptionally active chromatin. , 1988, The EMBO journal.
[26] G. Otterson,et al. The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. , 2003, Current medicinal chemistry. Anti-cancer agents.
[27] J. Herman,et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.
[28] H. Iwata,et al. DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers , 1999, British Journal of Cancer.